Abstract
Age-specific serum PSA reference ranges have recently been proposed to be more sensitive in young and more specific in elder patients. However, some conflicting results have been reported from different centers.
In order to establish age-specific PSA reference ranges for our country, we measured the serum PSA levels of 400 healthy men over 40, between February 1995 and June 1996. Our study population consisted of men who had either PSA values lower than 4.0 ng/ml and normal digital rectal examination or negative prostatic biopsies taken for any reason. IMX assay was used for PSA determination in all patients.
Mean PSA values and standard deviations for each age group were: 1.7±1.1 ng/ml for 40–49 years (n=28), 2.0±1.2 ng/ml for 50–59 years (n=110), 2.9±1.7 ng/ml for 60–69 years (n=158) and 3.5±2.0 ng/ml for 70–79 years (n=104).
We conclude that further studies of larger series will lead us to standardize age-specific reference ranges in our country and, accordingly, we will be able to select the candidates for prostate biopsy more adequately.
Similar content being viewed by others
References
Rommel, F. M., Agusta, V. E., Breslin, J. A., Huffnagle, H. W., Pohl, C. E., Sieber, P. R., Stahl, C. A.: The use of prostate specific antigen and prostate specific antigen density in the diagnosis of prostate cancer in a community based urology practice.J. Urol., 151, 88 (1994).
Ablin, R. J., Soanes, W. A., Bronson, P.: Precipitating antigens of the normal human prostate.J. Reprod. Fertil, 22, 573 (1970).
Hara, M., Koyonagi, Y., Inoue, T., Fukuyara, T.: Some physiochemical characteristics of gamma seminoprotein, and antigenic component specific for human seminal plasma. Forensic immunological study of body fluids and secretions.Jap. J. Legal Med., 25, 322 (1971).
Kuriyama, M., Wang, M. C., Pepsidore, L. D., Killian, C. S., Murphy, G. P.: Quantitation of prostate-specific antigen in serum by a sensitive enzyme immunoassay.Cancer Res., 40, 4658 (1980).
Chan, D. W., Bruzek, D. J., Oesterling, J. E., Rock, R. C., Wals, P. S.: Prostate specific antigen as a marker for prostate cancer: A monoclonal and a polyclonal immunoassay compared.Clin. Chem., 33, 1916 (1987).
Oesterling, J. E., Chan, D. W., Epstein, J. I., Kimball, A. W., Brendler, C. B., Walsh, P. C.: Prostate specific antigen in the preoperative and postoperative evaluation of localized prostatic cancer treated with radical prostatectomy.J. Urol., 139, 766 (1988).
Yuan, J. J. J., Coplen, D. E., Petro, J. A., Figenshau, R. S., Ratliff, T. L., Catalona, W. F.: Effects of rectal examination, prostatic massage, ultrasonography and needle biopsy on serum prostate specific antigen levels. Part 2.J. Urol., 147, 810 (1992).
Pearson, J. D., Carter, H. B.: Natural history of changes in prostate specific antigen in early stage prostate cancer.J. Urol., 152, 1743 (1994).
Stamey, T. A., Yang, N., Anderson, K., Redwinw, E.: Prostate specific antigen as a serum marker for adenocarcinoma of the prostate.N. Engl. J. Med., 317, 909 (1987).
Partin, A. W., Carter, H. B., Chan, D. W., Rock, R. C., Walls, P. C.: Prostate specific antigen in the staging of localized prostate cancer: Influence of tumor differentiation, tumor volume and benign hyperplasia.J. Urol., 143, 747 (1990).
Hudson, M. A., Bahnson, R. R., Catalona, W. J.: Clinical use of prostate specific antigen in patients with prostate cancer.J. Urol., 142, 1011 (1989).
Ruckle, H. C., Klee, G. G., Oesterling, J. E.: Prostate specific antigen: Critical issues for the practicing physician.Mayo Clin. Proc., 69, 59 (1994).
Oesterling, J. E., Chute, C. G., Jacobsen, S. J., Johnson, C. L., Lieber, M. M.: Longitudinal changes in serum PSA in a community-based cohort of men. Part 2.J. Urol., 149, 412 (1993).
Oesterling, J. E., Jacobsen, S. F., Chute, C. G., Guess, H. A., Lieber, M. M.: Serum prostate specific antigen in a community based population of healthy men. Establishment of age-specific reference ranges.J.A.M.A., 270, 860 (1993).
Dalkin, B. L., Ahmann, F., Southwick, P., Bottachini, M. R.: Derivation of normal prostate specific atigen levels by age. Part 2.J. Urol., 149, 413. Abstract 803 (1993).
Riċhie, J. P., Catalona, W. J., Ahmann, F. R., Scardino, P. T., Southwick, P. C.: Effect of patient age on early detection of prostate cancer with serum prostate specific antigen and digital rectal examination.Urology, 42, 365 (1993).
Catalona, W. J., Hudson, M. A., Scardino, P. T., Richie, J. P., Southwick, P. C.: Selection of optimal prostate cancer: Receiver operating characteristic curves.J. Urol., 152, 2037 (1994).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Atalay, A.C., Karaman, M.I., Güney, S. et al. Age-specific PSA reference ranges in a group of non-urologic patients. International Urology and Nephrology 30, 587–591 (1998). https://doi.org/10.1007/BF02550550
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02550550